Peregrine Pharmaceuticals shares owned by Credit Suisse
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $815k | 125k | 6.50 |
| 2023-09-30 | $752k | 80k | 9.44 |
| 2023-06-30 | $1.4M | 98k | 13.97 |
| 2023-03-31 | $1.4M | 75k | 18.76 |
| 2022-12-31 | $1.0M | 73k | 13.77 |
| 2022-09-30 | $1.3M | 70k | 19.10 |
| 2022-06-30 | $992k | 65k | 15.22 |
| 2022-03-31 | $1.8M | 89k | 20.27 |
| 2021-12-31 | $2.0M | 70k | 29.11 |
| 2021-09-30 | $1.5M | 69k | 21.43 |
| 2021-06-30 | $996k | 39k | 25.83 |
| 2020-12-31 | $209k | 18k | 11.58 |
| 2019-09-30 | $66k | 12k | 5.26 |
| 2019-06-30 | $67k | 12k | 5.55 |
| 2019-03-31 | $49k | 12k | 4.18 |
| 2018-06-30 | $53k | 14k | 3.89 |